| Treatment and referral decisions under different physician payment mechanisms M Allard, I Jelovac, PT Léger Journal of health economics 30 (5), 880-893, 2011 | 123 | 2011 |
| GPs’ payment contracts and their referral practice BG Mariñoso, I Jelovac Journal of Health Economics 22 (4), 617-635, 2003 | 93 | 2003 |
| Pricing and welfare implications of parallel imports in the pharmaceutical industry I Jelovac, C Bordoy International journal of health care finance and economics 5, 5-21, 2005 | 91 | 2005 |
| Comparing organizational structures in health services I Jelovac, I Macho-Stadler Journal of Economic Behavior & Organization 49 (4), 501-522, 2002 | 54 | 2002 |
| Physicians' payment contracts, treatment decisions and diagnosis accuracy I Jelovac Health Economics 10 (1), 9-25, 2001 | 50 | 2001 |
| How should donors give foreign aid? A theoretical comparison of aid modalities I Jelovac, F Vandeninden The European Journal of Development Research 26, 886-904, 2014 | 44* | 2014 |
| External referencing and pharmaceutical price negotiation B Garcia Mariñoso, I Jelovac, P Olivella Health Economics 20 (6), 737-756, 2011 | 41 | 2011 |
| Drug launch timing and international reference pricing N Houy, I Jelovac Health Economics 24 (8), 978-989, 2015 | 31 | 2015 |
| On the relationship between the negotiated price of pharmaceuticals and the patients’ co-payment I Jelovac Economics Bull 2015 35, 481-93, 2015 | 29* | 2015 |
| Household health-seeking behaviour in Khartoum, Sudan: the willingness to pay for public health services if these services are of good quality K Habbani, W Groot, I Jelovac Health policy 75 (2), 140-158, 2006 | 28 | 2006 |
| Payment mechanism and GP self-selection: capitation versus fee for service M Allard, I Jelovac, PT Léger International Journal of Health Care Finance and Economics 14, 143-160, 2014 | 25 | 2014 |
| Primary Care, gatekeeping and incentives I Jelovac HAL Post-Print, 2014 | 15 | 2014 |
| Physicians’ balance billing, supplemental insurance and access to health care I Jelovac International journal of health economics and management 15, 269-280, 2015 | 11 | 2015 |
| Research funding and price negotiation for new drugs F Barigozzi, I Jelovac Health Economics 29, 83-96, 2020 | 9 | 2020 |
| Comparing approval procedures for new drugs N Houy, I Jelovac The World Economy 42 (5), 1598-1619, 2019 | 9* | 2019 |
| Regulation and altruism I Jelovac, S Kembou Nzale Journal of Public Economic Theory 22 (1), 49-68, 2020 | 6 | 2020 |
| Incentives to patients versus incentives to health care providers: The users' perspective I Jelovac, P Polomé Health economics 26 (12), e319-e331, 2017 | 6 | 2017 |
| Do free-of-charge public health services impede cost recovery policies in Khartoum state, Sudan? K Habbani, W Groot, I Jelovac EMHJ-Eastern Mediterranean Health Journal, 13 (4), 939-952, 2007, 2007 | 5 | 2007 |
| Nobel prizes in economics at the service of health systems C Franc, I Jelovac Medecine sciences: M/S 34 (3), 261-266, 2018 | 1* | 2018 |
| Competition in Health Provision and Insurance PP Barros, BG Mariñoso, I Jelovac, P Olivella Fundacion BBVA, 2006 | 1 | 2006 |
Pierre Thomas LegerUniversity of Illinois at ChicagoVerified email at uic.edu
